Toxicology of Acarbose, with Special Reference to Long-term Carcinogenicity Studies

  • Conference paper
Acarbose for the Treatment of Diabetes Mellitus

Abstract

Acarbose is a glucosidase inhibitor which exerts its activities within the gastrointestinal tract of animals and humans [1]. The drug delays glucose absorption and thus represents a new therapeutical concept in the treatment of diabetes mellitus. The mean therapeutic dose is three times 100-mg tablets [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 85.59
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 106.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Puls W, Keup U, Krause HP, et al. (1980) Pharmacology of a glucosidase inhibitor. Front Hormone Res 7:235

    CAS  Google Scholar 

  2. Schöffling K, Hillebrand I (1981) Acarbose — ein neues therapeutisches Prinzip in der Behandlung des Diabetes mellitus. Dtsch Med Wochenschr 106:1083

    Article  PubMed  Google Scholar 

  3. Schlüter G (1982) Toxicology of acarbose. In: Creutzfeldt W (ed) First international symposium on acarbose. Excerpta Medica, Amsterdam

    Google Scholar 

  4. Tucker MJ (1979) The effect of long-term food restriction on tumors in rodents. Int J Cancer 23:803–807

    Article  PubMed  CAS  Google Scholar 

  5. Cheney KE, Liu RK, Smith GS, Leung RE, Mickey MR, Walford RL (1980) Survival and disease patterns in C57BL 46J mice subjected to undernutrition. Exp Gerontol 15:237–258

    Article  PubMed  CAS  Google Scholar 

  6. Weindruch R, Walford RL (1982) Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 215:1415–1418

    Article  PubMed  CAS  Google Scholar 

  7. Woutersen RA (1987) Chronic toxicity and carcinogenicity of lactitol in rats: comparison with lactose. In: Leegater DC, Feron VJ, Hermus RJJ (eds) Low-digestibility carbohydrates. Proceedings of a workshop held at the TNO-CINO Institutes, Zeitst, the Netherlands, 27–28 November 1986)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schlüter, G. (1988). Toxicology of Acarbose, with Special Reference to Long-term Carcinogenicity Studies. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73583-7_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19145-2

  • Online ISBN: 978-3-642-73583-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation